stockrowCytomX Therapeutics, Inc. (CTMX) vs Shattuck Labs, Inc. (STTK)
- CytomX Therapeutics, Inc. CTMX 2.19 +2.34%
- Shattuck Labs, Inc. STTK 4.59 +2.23%
CytomX Therapeutics, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. CytomX Therapeutics, Inc. and Shattuck Labs, Inc. are of similar size ($466.3M and $450.6M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −87.7%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −630.4%) and the lower return on invested capital (−1,230.7% vs −20.8%). Across the 16 metrics below, Shattuck Labs, Inc. leads on 10 and CytomX Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | CTMX | STTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (676.45%) | 0.00% | 0.00% |
| Net margin | (630.38%) | 0.00% | 0.00% |
| Free cash flow margin | (362.89%) | 0.00% | 0.00% |
| Return on equity | (45.08%) | (39.21%) | (51.96%) |
| Return on assets | (33.82%) | (36.88%) | (46.06%) |
| Return on invested capital | (20.82%) | (1,230.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack